Bionova Capital
VC Fund
Lisbon, Portugal
Bionova Capital is a VC fund in Lisbon focused on Biotechnology and Medical. Bionova Capital, previously known as Hovione Capital, is a healthcare-focused venture capital firm, investing in early-stage life science companies. It was founded in 2015 by the shareholders of Hovione, one of the largest pharmaceutical companies in Portugal, with manufacturing and research operations in USA, Ireland, China and Portugal. BionovaCapital invests in groundbreaking therapeutics, medtech and digital health startups across Europe.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries Bionova Capital invests in
Stages Bionova Capital invests in
Countries Bionova Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $329k–$1.9M
Investment Focus
Industry
- Biotechnology 3 (27%)
- Medical 2 (18%)
- Health Care 2 (18%)
- Hospital 1 (9%)
- Software 1 (9%)
Stage
- Seed 5 (45%)
- Pre-Seed 1 (9%)
- Series A 1 (9%)
- Venture - Series Unknown 1 (9%)
Country
- Portugal 3 (27%)
- United Kingdom 2 (18%)
- Spain 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
João Ventura Fernandes
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
Peter Villax
Chairman
|
Chairman | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design, development, and production of a vast portfolio of automatic biodecontamination robots. Target applications include the sterilization of medical devices in hospitals, health centers and field hospitals (for humanitarian missions,catastrophe situations, and war zones); room biodecontamination in hospitals, pharma, food industry and space; and laboratory equipment biodecontamination. | $785.5K / Seed / May 18, 2022 | ||
| SolasCure aims to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds. | $20.8M / Series A / Aug 09, 2021 | ||
| Adapttech is a biomedical company that creates innovative, smart, and wearable technologies to assist people with physical disabilities in improving their quality of life. It aims to provide clinicians with better socket fitting and monitoring methods in order to improve the quality of life for people who have lost a lower limb. | $2.7M / Venture - Series Unknown / Mar 23, 2021 | ||
| Vaxdyn develops vaccines using novel technology. They offers pathogen vaccines for preventing antibiotics-resistant infections. Their customers' inquiries are addressed through phone, email, and online applications. | $355.5K / Seed / Mar 08, 2021 | ||
| Pharmaceutical Company, Biotechnology | $1.6M / Seed / Nov 13, 2019 | ||
| Pharmaceutical Company, Biotechnology | $1.6M / Seed / Jun 25, 2019 | ||
| Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design, development, and production of a vast portfolio of automatic biodecontamination robots. Target applications include the sterilization of medical devices in hospitals, health centers and field hospitals (for humanitarian missions,catastrophe situations, and war zones); room biodecontamination in hospitals, pharma, food industry and space; and laboratory equipment biodecontamination. | $329K / Seed / Jul 01, 2018 | ||
| Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design, development, and production of a vast portfolio of automatic biodecontamination robots. Target applications include the sterilization of medical devices in hospitals, health centers and field hospitals (for humanitarian missions,catastrophe situations, and war zones); room biodecontamination in hospitals, pharma, food industry and space; and laboratory equipment biodecontamination. | $350.4K / Pre-Seed / Jul 01, 2018 | ||
| Adapttech is a biomedical company that creates innovative, smart, and wearable technologies to assist people with physical disabilities in improving their quality of life. It aims to provide clinicians with better socket fitting and monitoring methods in order to improve the quality of life for people who have lost a lower limb. | $1.9M / Seed / May 16, 2016 | ||
| Anybrain is a artificial intelligence and data processing firm. | Seed / Oct 30, 2015 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Bionova Capital invest in?
Bionova Capital invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in Portugal. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Bionova Capital's check size?
Bionova Capital typically joins rounds of $329k–$1.9M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Bionova Capital participates in.
How do I contact Bionova Capital?
Public channels for Bionova Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bionova Capital?
The team at Bionova Capital includes João Ventura Fernandes (Venture Partner) and Peter Villax (Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
